Note, 2024

Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1 - Time to Reassess the Evidence

JAMA Oncology, ISSN 2374-2437, 2374-2445, 10.1001/jamaoncol.2024.1117

Contributors

Donia M. 0000-0003-4966-9752 (Corresponding author) [1] Prasad V. 0000-0002-6110-8221 (Corresponding author) [2]

Affiliations

  1. [1] Copenhagen University Hospital
  2. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Department of Medicine
  4. [NORA names: United States; America, North; OECD]

Data Provider: Elsevier